バイオテクノロジーニュース
-
January 16 , 2020
Chinese Immuno-Oncology Firm I-Mab's IPO Lands on NASDAQ
- I-Mab is the first Chinese company in two years to try the US boards for an IPO.
詳しく見る -
January 10 , 2020
Biotech Stocks Facing FDA Decision In January 2020
- As we begin the first month of the year 2020, it’s time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency's decision.
詳しく見る -
January 1 , 2020
First China-made HPV vaccine approved
- BEIJING, Jan. 2 (Xinhua) -- China has approved the first domestically produced vaccine against the cancerogenic human papillomavirus (HPV), according to the National Medical Products Administration (NMPA).
詳しく見る -
December 20 , 2019
Tracon Pharma Acquires US Rights to 3D Medicines/Alphamab PD-L1
- SAN DIEGO, Dec. 20, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc.(NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, announced today that it has signed a collaborative partnership agreement with 3D Medicines (Beijing) Co., Ltd., a China-based biopharmace
詳しく見る -
December 12 , 2019
GEN：Top 10 Immuno-Oncology Startups of 2019
- Alex Trebek appeared well en route to surviving pancreatic cancer this past summer when his doctors followed up his initial successful chemotherapy with an undisclosed immunotherapy. That move backfired.
詳しく見る